Multiple switching between the biosimilar adalimumab PF-06410293 and reference adalimumab in patients with active rheumatoid arthritis: a phase 3, open-label, randomised, parallel-group study
| Autor: | Fleischmann, Roy M *, Saikali, Wassim, Lakhanpal, Sharad, Alvarez, Daniel F, Cox, Donna S, Ianos, Claudia Ana, Zhang, Wuyan, Cronenberger, Carol, Wang, Karen |
|---|---|
| Zdroj: | In The Lancet Rheumatology September 2023 5(9):e532-e541 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|